Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman(Peter Doherty Institute), Tobias Sejbæk(University of Southern Denmark), Melinda Magyari(University of Copenhagen), Murat Terzi(Ondokuz Mayıs University), Leszek Stawiarz(Karolinska Institutet), Jeannette Lechner‐Scott(John Hunter Hospital), Nevin John(Monash Health), María Trojano(University of Bari Aldo Moro), Radek Ampapa(Hospital Jihlava), Sandra Vukusic(Institut NeuroMyoGène), Tomáš Kalinčík(The Royal Melbourne Hospital), Dana Horáková(Charles University), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Patrice H. Lalive(University Hospital of Geneva), María José Sá(Fernando Pessoa University), Bassem Yamout(American University of Beirut Medical Center), Anneke van der Walt(The Alfred Hospital), Sara Eichau(Hospital Universitario Virgen Macarena), Jihad Inshasi(Rashid Hospital), Pietro Iaffaldano(University of Bari Aldo Moro), Julie Prévost(Cegep de Saint Jerome), Raed Alroughani(Amiri Hospital), Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Pamela McCombe(The University of Queensland), Seyed Aidin Sajedi(Golestan University), Peter Vestergaard Rasmussen(Aarhus University Hospital), François Grand’Maison, Samia J. Khoury(Brigham and Women's Hospital), Luigi Pontieri(Rigshospitalet), Robert Hyde(Biogen (Switzerland)), Aysun Soysal(Bakırköy Psychiatric Hospital), Rana Karabudak(Hacettepe University), Oliver Gerlach(Maastricht University), Fabio Pellegrini(Biogen (Switzerland)), Ayşe Altıntaş(Istanbul University), Jiří Drahota(Charles University), Ali Manouchehrinia(Karolinska Institutet), Chris McGuigan(St. Vincent's University Hospital), Vahid Shaygannejad(Isfahan University of Medical Sciences), Celia Oreja‐Guevara, Serkan Özakbaş(İzmir University of Economics), Yolanda Blanco(Fundació Clínic per a la Recerca Biomèdica), Lars Forsberg, Marc Girard(Université de Montréal), Olga Skibina(Box Hill Hospital), Hanna Joensen(Rigshospitalet), Anna Glaser(Karolinska Institutet), Koen de Gans(Groene Hart Ziekenhuis), Stella Hughes(University of Ulster), Finn Sellebjerg(Danish Multiple Sclerosis Center)
Cited by 9
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
Multiple Sclerosis Severity Score
|Neurology|2005|957
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624